A small pilot study suggests Epidiolex may have benefits for weight restoration and symptom improvement in anorexia patients.
Two non-psychoactive cannabis compounds may help treat the most common form of chronic liver disorder.
The company has cleared the final regulatory hurdle to begin its ENDOCAN Phase 2 trial in women with endometriosis-associated pain.
A balanced CBD and THC cannabis flower was found to be more effective for treating acute migraine symptoms than a placebo.
Lab studies find that a combination of THC and CBD kills ovarian cancer cells without harming healthy cells
The UK’s long-running project to regulate CBD (cannabidiol) products has taken another major step forward, seeing thousands of products make it to the final phase of...
A new clinical trial will investigate the potential of cannabis-based treatment to improve quality of care for hospice eligible patients with dementia.
In the first controlled clinical trial of CBD in boys with autism, two-thirds of participants showed behavioural improvements with treatment.
The UK’s Food Standards Agency (FSA) has announced some significant updates to its multi-year CBD Novel Foods approvals process.
Two cannabis-derived compounds have shown remarkable effectiveness against fungal pathogens in laboratory tests, according to new research. In a study published in The Journal of Neglected Tropical...